KimerApt therapy (Regen Biopharma Inc)

N/A

Report date: 2024/09/24 10:49:37

Base Information

Drug NameKimerApt therapy (Regen Biopharma Inc)
Drug Alias NameBi-specific aptamers therapy (Regen Biopharma Inc)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegen Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesRegen Biopharma
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A